Results 141 to 150 of about 34,268 (231)

Design of cyclic peptides with biological activities from biologically active peptides: the case of peptide modulators of melanocortin receptors. [PDF]

Biopolymers, 2016
Hruby VJ.
europepmc   +1 more source

Video 2_Differential potentiation of odor aversion and yawning by melanocortin 4 receptor signaling in distinct regions of the ventral striatum.mp4

Md Tasnim Alam (22556144), Md Monjurul Ahasan (15254227), Shogo Shimizu (787801), Yoshihiro Murata (16868541), Mutsuo Taniguchi (16868544), Masahiro Yamaguchi (204795)   +5 more
openalex   +2 more sources

Discovery of (2S)-N-[(1R)-2-[4-cyclohexyl-4-[[(1,1-dimethylethyl)amino]carbonyl]-1-piperidinyl]-1-[(4-fluorophenyl)methyl]-2-oxoethyl]-4-methyl-2-piperazinecarboxamide (MB243), a potent and selective melanocortin subtype-4 receptor agonist

, 2004
Brenda L. Palucki, Min K. Park, Ravi P. Nargund, Zhixiong Ye, Iyassu K. Sebhat, Patrick G. Pollard, Rubana N. Kalyani, Rui Tang, Tanya MacNeil, David H. Weinberg, Aurawan Vongs, Charles Rosenblum, George A. Doss, Randall R. Miller, Ralph A. Stearns, Qianping Peng, Constantin Tamvakopoulos, Erin McGowan, William J. Martin, Joseph M. Metzger, Cherrie Shepherd, Alison M. Strack, D. Euan MacIntyre, Lex H.T. Van der Ploeg, Arthur A. Patchett   +24 more
openalex   +1 more source

Cart Overexpression Is the Only Identifiable Cause of High Bone Mass in Melanocortin 4 Receptor Deficiency [PDF]

, 2006
Jong Deok Ahn, Béatrice Dubern, Cécile Lubrano-Berthelier, Karine Clément, Gérard Karsenty   +4 more
openalex   +1 more source

Video 1_Differential potentiation of odor aversion and yawning by melanocortin 4 receptor signaling in distinct regions of the ventral striatum.mp4

Md Tasnim Alam (22556144), Md Monjurul Ahasan (15254227), Shogo Shimizu (787801), Yoshihiro Murata (16868541), Mutsuo Taniguchi (16868544), Masahiro Yamaguchi (204795)   +5 more
openalex   +2 more sources

Activation of Melanocortin Receptors MC 1 and MC 5 Attenuates Retinal Damage in Experimental Diabetic Retinopathy. [PDF]

Mediators Inflamm, 2016
Rossi S, Maisto R, Gesualdo C, Trotta MC, Ferraraccio F, Kaneva MK, Getting SJ, Surace E, Testa F, Simonelli F, Grieco P, Merlino F, Perretti M, D'Amico M, Di Filippo C.   +14 more
europepmc   +1 more source

MGRN1 in development and disease: a unifying view of a versatile membrane-tethered E3 ubiquitin ligase. [PDF]

Biochem Soc Trans
Riglos A, Gunn TM, Kong JH.
europepmc   +1 more source

Hypothalamic obesity. [PDF]

Rev Endocr Metab Disord
Farooqi IS, O'Rahilly S.
europepmc   +1 more source

Developing a Biased Unmatched Bivalent Ligand (BUmBL) Design Strategy to Target the GPCR Homodimer Allosteric Signaling (cAMP over β-Arrestin 2 Recruitment) Within the Melanocortin Receptors. [PDF]

J Med Chem, 2019
Lensing CJ, Freeman KT, Schnell SM, Speth RC, Zarth AT, Haskell-Luevano C.   +5 more
europepmc   +1 more source

Targeting Peptidergic Systems for Melanoma Treatment. [PDF]

Cancers (Basel)
Sánchez ML, Mehboob R, Coveñas R.
europepmc   +1 more source